Back to Search Start Over

COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?

Authors :
Kutti Sridharan G
Kotagiri R
Chandiramani VH
Mohan BP
Vegunta R
Vegunta R
Rokkam VRP
Source :
American journal of therapeutics [Am J Ther] 2020 Jul/Aug; Vol. 27 (4), pp. e400-e402.
Publication Year :
2020

Abstract

Ibuprofen is an over-the-counter medication that is used widely for the treatment of pain and fever during COVID-19 pandemic. A concern was raised regarding the safety of ibuprofen use because of its role in increasing ACE2 levels within the Renin-Angiotensin-Aldosterone system. ACE2 is the coreceptor for the entry of SARS-CoV-2 into cells, and so, a potential increased risk of contracting COVID-19 disease and/or worsening of COVID-19 infection was feared with ibuprofen use. However, available data from limited studies show administration of recombinant ACE2 improves lung damage caused by respiratory viruses, suggesting ibuprofen use may be beneficial in COVID-19 disease. At this time, there is no supporting evidence to discourage the use of ibuprofen.

Details

Language :
English
ISSN :
1536-3686
Volume :
27
Issue :
4
Database :
MEDLINE
Journal :
American journal of therapeutics
Publication Type :
Academic Journal
Accession number :
32366740
Full Text :
https://doi.org/10.1097/MJT.0000000000001196